Skip to Content
COVID-19 Resources
Cancer Imaging Program (CIP)
Contact CIP
Show menu
Search this site
Last Updated: 10/28/16

Newsletter No. 123 — January 2010

Grant Application Information:
Good place to look for information about new application format:

NIH Funding
Application Receipt Date(s): March 23, 2010
The NCRR Shared Instrument Grant (SIG) program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instrumentation or an integrated system that costs at least $100,000. The maximum award is $600,000.

Letter of Intent due to IC representative: over 6 weeks prior to application
Application due dates: Standard dates: April 12, August 12, December 12
The purpose is to support high quality conferences/scientific meetings relevant to the scientific mission of the NIH and to the public health. In addition, applicants are encouraged to consult the Frequently Asked Questions Website for more detailed information about this program:

PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])(PA-10-050)
PHS 2010-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])(PA-10-051)

Image-Guided Cancer Interventions (NCI)(SBIR [R43/R44])(SBIR PA-10-079)
Image-Guided Cancer Interventions (NCI)(STTR [R41/R42])(STTR PA-10-080)
Application Due Dates: Standard Dates Apply
This FOA encourages SBIR and STTR grant applications from small business concerns (SBCs) that propose the development and clinical validation of systems for image-guided interventions (IGIs) for cancer.

SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) (NCI) (RFA-CA-10-009)
Letter of Intent Receipt Date: February 1, 2010
Application Due Date: March 1, 2010
This FOA solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded by NIH SBIR Phase II awards. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices and in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics.

Recovery Act Limited Competition: Institutional Comparative Effectiveness Research Mentored Career Development Award (KM1) (multiple ICs, including NCI) (RFA-OD-10-011)
Application Due Date: March 25, 2010
The NIH invites applications from research-intensive institutions to support mentored career development in support of comparative effectiveness research (CER) in an interdisciplinary environment catering to the needs of diverse populations of scholars including (but not limited to) those with backgrounds in biostatistics, epidemiology, health economics, pharmacology, medicine, and dentistry. A pre-submission videoconference will be conducted on February 10, 2010, from 2:00 to 4:00 pm ET at which NCI and other NIH staff will explain the goals and objectives of this Mentored Career Development Program and answer questions. All prospective applicants are invited to view the meeting through videoconference or videocast at The meeting videocast will be archived at A Frequently Asked Questions website will be announced at a later date. A listserve, ARRA_CER_KM1_apply, located at will be used to notify applicants of the website, videocast and any changes to the FAQ.

NIH Exploratory Developmental Research Grant Program (Parent R21)(Mulitiple ICs, NOT NCI) (PA-10-069)
Application Receipt/Submission Date(s): Multiple dates, see announcement.
The R21 funding supports the development of new research activities in categorical program areas. Investigators are strongly encouraged to consult the list of participating ICs and special research interests.

Application Receipt/Submission Date(s): Multiple dates, see announcement.
The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation’s research scientists, but that have not been major recipients of NIH support.

Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (NIMH) (SBIR [R43/R44]) (PA-10-081)
Application Due Dates: Standard Dates Apply
Grant applications are encouraged from small business concerns (SBCs) that propose to develop technologies and approaches (i.e., novel ways to use new or existing technologies) that will enable researchers to study the structure and/or function of brain localized G-protein coupled receptor proteins (GPCRs) and/or potentially identify novel selective and specific agonists/antagonists to these receptor subtypes, with a focus on mental health function or dysfunction, including HIV-related neurocognitive disorders. Examples include molecular imaging techniques.

Letters of Intent Due: 30 days before application receipt date
Application Receipt Dates: March 8, June 1, October 1, 2010; February 1, June 1, Sept 30, 2011; February 1, June 1, October 1, 2012.
The NIDCD P30 Core Center grant contains one or more research-serving cores, providing centralized resources and facilities for funded R01 research projects. Resources provided may include complex resources such as brain imaging and innovative technical solutions such as imaging or novel hardware development.

Letters of Intent Receipt Date: February 15, 2010
Application Receipt Date(s): March 15, 2010
This program will support projects that address research endeavors in specific areas that will benefit from significant three-year funds without the expectation of continued NIH funding beyond this period. Applicants must be a domestic (United States) institution/organization. Topics: `.
1. Applying Genomics and Other High Throughput Technologies (may include new imaging modalities);
2. Translating Basic Science Discoveries into New and Better Treatments
3. Using Science to Enable Health Care Reform;
4. Focusing on Global Health; and
5. Reinvigorating the Biomedical Research Community: This theme encourages investigators to cultivate new collaborations and to assemble multidisciplinary or interdisciplinary teams in conducting innovative research on the most challenging biomedical and behavioral areas

Other Funding Agencies

NSF Major Research Instrumentation Program: Instrument Acquisition or Development (NSF 10-529)

Full Proposal Deadline(s) (due by 5 p.m. proposer’s local time): April 21, 2010. Pending the availability of funds, it is anticipated that MRI program deadlines will occur on the fourth Thursday in January annually thereafter.
The program will not provide support for instrumentation to be used in medical education (such as medical school courses). Instrumentation intended for research with disease-related goals, including work on the etiology, diagnosis or treatment of physical or mental disease, abnormality, or malfunction in human beings or animals, is normally not supported. Instrumentation for research on animal models of such conditions or the development or testing of drugs or other procedures for their treatment also is not eligible for support. However, instrumentation for bioengineering research, with diagnosis- or treatment-related goals that applies engineering principles to problems in biology and medicine, while also advancing engineering knowledge, is eligible for support. Instrumentation for bioinformatics, biocomputing and bioengineering research to aid persons with disabilities also is eligible.

American Cancer Society. MEN2 Thyroid Cancer Consortium - Research
Scholar Grants, Mentored Research Scholar Grants, and Postdoctoral Fellowships
Application Deadline: April 1,2010
The American Cancer Society announces this revised request for applications for the American Cancer Society MEN2 Thyroid Cancer Consortium. Funds remain available for up to seven Research Scholar and/or Mentored Research Scholar grants, and up to five postdoctoral fellow grants will be awarded. The consortium will be led by a single renowned senior scientist who will be awarded the American Cancer Society MEN2 Thyroid Cancer Professorship and act as leader for the overall program. Appropriate areas of investigation include, but are not limited to: understanding consequences of RET mutations, molecular events underlying the development of MEN2-related tumors, improved animal models of MEN2, new screening and monitoring tools, new imaging approaches, and new pharmacologic and other strategies to blunt the effects of mutations in RET and other genes associated with medullary thyroid cancer.

Interagency Oncology Task Force Fellowship Opportunities
The Interagency Oncology Task Force (IOTF), a joint initiative between the National Cancer Institute NCI and the U. S. Food and Drug Administration announces this year’s fellowship training opportunities for Ph.D.s, M.D.s, and M.D./Ph.D.s or their equivalents in cancer-related scientific research and research-related regulatory review. Fellowship programs are available for various career levels and vary in length (1- 4 years). View each program’s web page for more information, including application deadlines and start dates.
The IOTF was established to enhance and accelerate the overall process of developing new cancer diagnostics and therapeutics and devices and speed their delivery to patients.


Guidance on Impact and Significance in the enhanced review criteria, a set of FAQs, and case studies have been posted among the Guidelines for Reviewers on the OER Peer Review Policies and Practices page: Please share this information and link with your staff, reviewers and applicants.

Error-Correction Window Extended for Electronic Applications Intended for Submission Deadlines On and Between January 25 and May 7, 2010 (NOT-OD-10-042)
Related Guide Notices:
NOT-OD-09-149: Restructured Application Forms and Instructions for Submissions for FY2011 Funding
NOT-OD-10-016: Now Available: Restructured Application Forms and Instructions for Application Due Dates on or after January 25, 2010

NIH Fiscal Policy for Grant Awards FY 2010 (NOT-OD-10-039)

CIP Announcements
Washington University, St Louis, MO, June 20-25, 2010
Application Deadline: February 12, 2010
Postdoctoral fellows and early career-level faculty in fields related to basic cancer biology are invited to apply for a special intensive course on in vivo and live cell-imaging techniques. Through lectures and hands-on laboratory sessions, participants will gain experience with a wide range of imaging modalities, including advanced optical imaging, MRI, PET, SPECT, CT, and ultrasound.

The Cancer Imaging Program’s DCIDE program for providing data to investigators for their IND filings is being absorbed by the NCI Experimental Therapeutics Program (NExT). Submissions are due quarterly, on the 15th of February, May, August and November.

The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.

SPIE Medical Imaging Conference
February 13 - 18, 2010, Town & Country Resort & Convention Center, San Diego, California

2010 NIH Regional Seminars on Program Funding and Grants Administration: Philadelphia, PA & Portland, OR
April 14-16, 2010, Philadelphia, PA
June 23-25, 2010, Portland, OR

Ultrasonic Imaging and Tissue Characterization
May 17-19, 2010, Holiday Inn Rosslyn at Key Bridge, Arlington, VA

57th Annual Society of Nuclear Medicine Meeting
June 5-9, 2010, Salt Lake City, Utah

CARS 2010 - Computer Assisted Radiology and Surgery
24th International Congress and Exhibition
Joint Congress of ISCAS, EuroPACS, CAR, CMI and CAD
June 23 - 26, 2010, University Medical Center, Geneva, Switzerland

Gordon Research Conference: Metals in Medicine
June 27 - July 2, 2010, Proctor Academy, Andover, NH

AAPM Annual Meeting, July 18-22, 2010, Pennsylvania Convention Center, Philadelphia, PA

AAPM Summer School:Teaching Medical Physics: Innovations in Learning
July 22-25, 2010, immediately following the 2010 AAPM Annual Meeting
University of Pennsylvania
SCHOLARSHIPS: Deadline to submit a scholarship application for the 2010 Summer School is February 11, 2010.

The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail ( Please include your complete mailing address, title, phone and fax numbers.

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507